AIM - AIM ImmunoTech Inc.
0.7
-0.073 -10.357%
Share volume: 192,884
Last Updated: 03-03-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.31%
PREVIOUS CLOSE
CHG
CHG%
$0.77
-0.07
-0.09%
View ratios
| Fiscal Date | 12-31-2024 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q2 2025 | Q3 2025 | |
| Report Date | 03-27-2025 | 08-14-2025 | 11-17-2025 | |
| Total revenue | 45.000 K | 25.000 K | 26.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 45.000 K | 25.000 K | 26.000 K | |
| -44.44% | 4.00% | |||
| Operating expenses | 5.893 M | 2.661 M | 2.405 M | |
| Selling general and admin | 4.229 M | 1.487 M | 1.798 M | |
| Research and development | 1.664 M | 1.174 M | 607.000 K | |
| Total expenses | 5.900 M | 2.671 M | 2.473 M | |
| -54.73% | -7.41% | |||
| Operating income | -5.855 M | -2.646 M | -2.447 M | |
| Ebit | -5.936 M | -2.646 M | -6.187 M | |
| Pretax income | -6.257 M | -2.804 M | -6.336 M | |
| -55.19% | 125.96% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -5.967 M | -2.794 M | -3.284 M | |
| 53.18% | -17.54% |